These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 2992682

  • 1. Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist.
    Ukai M, Kameyama T.
    Brain Res; 1985 Jul 01; 337(2):352-6. PubMed ID: 2992682
    [Abstract] [Full Text] [Related]

  • 2. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration.
    Wilson JL, Nayanar V, Walker JS.
    Br J Pharmacol; 1996 Aug 01; 118(7):1754-60. PubMed ID: 8842441
    [Abstract] [Full Text] [Related]

  • 3. An observational analysis of the effect of the selective kappa opioid agonist, U-50,488H, on feeding and related behaviours in the rat.
    Jackson A, Cooper SJ.
    Psychopharmacology (Berl); 1986 Aug 01; 90(2):217-21. PubMed ID: 3024197
    [Abstract] [Full Text] [Related]

  • 4. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.
    Leyton M, Stewart J.
    Brain Res; 1992 Oct 23; 594(1):56-74. PubMed ID: 1334765
    [Abstract] [Full Text] [Related]

  • 5. Observational analysis of the effects of kappa opioid agonists an open field behaviour in the rat.
    Jackson A, Cooper SJ.
    Psychopharmacology (Berl); 1988 Oct 23; 94(2):248-53. PubMed ID: 2895484
    [Abstract] [Full Text] [Related]

  • 6. The specific opioid kappa-agonist U-50,488H inhibits low Km GTPase.
    Ueda H, Misawa H, Fukushima N, Takagi H.
    Eur J Pharmacol; 1987 Jun 12; 138(1):129-32. PubMed ID: 3040426
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular actions of the kappa-agonist, U-50,488H, in the absence and presence of opioid receptor blockade.
    Pugsley MK, Penz WP, Walker MJ, Wong TM.
    Br J Pharmacol; 1992 Mar 12; 105(3):521-6. PubMed ID: 1320979
    [Abstract] [Full Text] [Related]

  • 8. Behavioural effect of pretreatment with opioid antagonists and sigma binding site ligands on the abnormal motor response produced by the kappa opioid agonist U50,488H in guinea pigs.
    Brent PJ.
    Neuropharmacology; 1993 Aug 12; 32(8):751-60. PubMed ID: 8413839
    [Abstract] [Full Text] [Related]

  • 9. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
    Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M, Nagase H.
    Jpn J Pharmacol; 1993 May 12; 62(1):15-24. PubMed ID: 8393497
    [Abstract] [Full Text] [Related]

  • 10. A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats.
    Yamamoto T, Ohno M, Ueki S.
    Eur J Pharmacol; 1988 Oct 26; 156(1):173-6. PubMed ID: 2850208
    [Abstract] [Full Text] [Related]

  • 11. Hyperalgesic effect of the selective kappa opioid agonist, U-50488H in mice.
    Ramabadran K.
    Jpn J Pharmacol; 1983 Dec 26; 33(6):1289-92. PubMed ID: 6321836
    [No Abstract] [Full Text] [Related]

  • 12. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY, Takemori AE.
    J Pharmacol Exp Ther; 1989 Aug 26; 250(2):508-14. PubMed ID: 2547935
    [Abstract] [Full Text] [Related]

  • 13. Ventral pallidal microinjections of receptor-selective opioid agonists produce differential effects on circling and locomotor activity in rats.
    Hoffman DC, West TE, Wise RA.
    Brain Res; 1991 Jun 07; 550(2):205-12. PubMed ID: 1653084
    [Abstract] [Full Text] [Related]

  • 14. Biochemical and behavioral studies on the interaction between mu- and kappa-opiate agonists in mice.
    Thorat SN, Veeranna, Reddy PL, Bhargava HN.
    Brain Res; 1993 Jul 02; 615(2):191-8. PubMed ID: 8395957
    [Abstract] [Full Text] [Related]

  • 15. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K, Tortella FC, Holaday JW, Long JB.
    J Pharmacol Exp Ther; 1993 Feb 02; 264(2):631-7. PubMed ID: 8382278
    [Abstract] [Full Text] [Related]

  • 16. Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord.
    Bhargava HN, Gulati A, Ramarao P.
    J Pharmacol Exp Ther; 1989 Oct 02; 251(1):21-6. PubMed ID: 2552075
    [Abstract] [Full Text] [Related]

  • 17. Effects of a selective kappa-opioid agonist, U-50,488H, on morphine dependence in rats.
    Fukagawa Y, Katz JL, Suzuki T.
    Eur J Pharmacol; 1989 Oct 24; 170(1-2):47-51. PubMed ID: 2558895
    [Abstract] [Full Text] [Related]

  • 18. Effects of U-50,488H, a kappa-opioid receptor agonist, on the learned helplessness model of depression in mice.
    Ukai M, Suzuki M, Mamiya T.
    J Neural Transm (Vienna); 2002 Sep 24; 109(9):1221-5. PubMed ID: 12203050
    [Abstract] [Full Text] [Related]

  • 19. The effect of kappa-opioid agonist U-50, 488H on wet-dog shaking behavior induced by hippocampal stimulation in rats.
    Ohno M, Yamamoto T, Araki H, Ueki S.
    Psychopharmacology (Berl); 1987 Sep 24; 91(2):189-92. PubMed ID: 3107029
    [Abstract] [Full Text] [Related]

  • 20. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
    Murray CW, Cowan A.
    J Pharmacol Exp Ther; 1991 Apr 24; 257(1):335-41. PubMed ID: 1850470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.